NASDAQHealth CareMedical - DevicesSnapshot 2026-08-31
Reading GEHC? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →Warn: Primary pillar under pressure — Revenue growth to about $4.9 billion per share in 2026: FY26 revenue growth guidance 3.0-4.0% vs trip condition <5.7%.
GE HealthCare aims to grow revenue and improve profit margins. It targets about $4.9 billion revenue per share in 2026. The company plans profit margins near 16% in 2026. Cash flow remains a focus with a $1.6 billion target for 2026.
Revenue and profit fell recently, showing trouble growing the business. Cash flow is uneven and operating income dropped from $827M to $515M. The company faces challenges meeting its goals and improving profits.
The price is about 21% below our fair value near $82. Analysts expect about 6% revenue growth. Our view aligns with the Street on growth but sees risks in profit and cash flow.
Breaks if: Free cash flow falls below $1.4 billion next year
Breaks if: Operating margin falls below 15% next year
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This is a durable compounder with a focus on steady growth. The current thesis state is intact, supported by strong recent financial results despite management volatility and sector risks.
The market currently prices GE Healthcare as cheap compared to its peers, with an expectations gap indicating that investors may not fully anticipate future growth. The valuation reflects a justified stance, with low fragility in the current regime.
Management aims for organic revenue growth of 3-4% in 2026, which is on track. However, the adjusted EBIT margin expansion is behind schedule, and cash flow generation remains mixed, indicating some variability in performance.
Key factors include the performance of sector bellwethers like Abbott and Medtronic, which could lift GE Healthcare if they continue to beat earnings. Additionally, any cuts to guidance or worsening economic indicators could negatively impact sentiment.
The most important moves since the prior daily snapshot.
Our read on the company is unchanged since the prior snapshot.
as of 2026-08-31
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Focus on improving operating income through cost management and efficiency.
Breaks if: Revenue growth falls below ~5.7% next year
Over the next 1 to 3 years, GE Healthcare's performance will depend on its ability to navigate sector dynamics and management execution. Not investment advice.
